Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2007-1-2
pubmed:abstractText
Helicobacter pylori (H. pylori), atrophic gastritis, dietary and life-style factors have been associated with gastric cancer (GC). These factors have been evaluated in a large case-control study nested in the European Prospective Investigation into Cancer and Nutrition carried out in 9 countries, including the Mediterranean area. Participants, enrolled in 1992-1998, provided life-style and dietary information and a blood sample (360,000; mean follow-up: 6.1 years). For 233 GC cases diagnosed after enrolment and their 910 controls individually-matched by center, gender, age and blood donation date H. pylori antibodies (antilysate and antiCagA) and plasma Pepsinogen A (PGA) were measured by ELISA methods. Severe chronic atrophic gastritis (SCAG) was defined as PGA circulating levels <22 microg/l. Overall, in a conditional logistic regression analysis adjusted for education, smoke, weight and consumption of total vegetables, fruit, red and preserved meat, H. pylori seropositivity was associated with GC risk. Subjects showing only antibodies anti-H. pylori lysate, however, were not at increased risk, while those with antiCagA antibodies had a 3.4-fold increased risk. Overall, the odds ratio associated with SCAG was 3.3 (95% CI 2.2-5.2). According to site, the risk of noncardia GC associated with CagA seropositivity showed a further increase (OR 6.5; 95% CI 3.3-12.6); on the other hand, a ten-fold increased risk of cardia GC was associated with SCAG (OR 11.0; 95% CI 3.0-40.9). These results support the causal relationship between H. pylori CagA+ strains infection, and GC in these European populations even after taking into account dietary habits. This association was limited to distal GC, while serologically defined SCAG was strongly associated with cardia GC, thus suggesting a divergent risk pattern for these 2 sites.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0020-7136
pubmed:author
pubmed-author:AllenNaomiN, pubmed-author:ArvanitiAthinaA, pubmed-author:BarricarteAurelioA, pubmed-author:BassoDanielaD, pubmed-author:BerglundGoranG, pubmed-author:BertiDuccioD, pubmed-author:BinghamSheilaS, pubmed-author:BoeingHeinerH, pubmed-author:Boutron-RuaultMarie-ChristineMC, pubmed-author:BuchnerFrederike LFL, pubmed-author:Bueno de MesquitaH BasHB, pubmed-author:CarneiroFatimaF, pubmed-author:CerotiMarcoM, pubmed-author:Clavel-ChapelonFrancoiseF, pubmed-author:Del GiudiceGiuseppeG, pubmed-author:E NumansMattijsM, pubmed-author:FerrariPietroP, pubmed-author:GonzalezCarlos ACA, pubmed-author:HallmansGoranG, pubmed-author:JenabMazdaM, pubmed-author:KaaksRudolfR, pubmed-author:KeyTimT, pubmed-author:KhawKay TeeKT, pubmed-author:KroghVittorioV, pubmed-author:LarrãnagaNereaN, pubmed-author:LinseisenJakobJ, pubmed-author:MasalaGiovannaG, pubmed-author:NagelGabrieleG, pubmed-author:NavarroCarmenC, pubmed-author:NesiGabriellaG, pubmed-author:NumansMattijs EME, pubmed-author:NyrénOlofO, pubmed-author:OlsenAnjaA, pubmed-author:OvervadKimK, pubmed-author:PalliDomenicoD, pubmed-author:PanicoSalvatoreS, pubmed-author:PeetersPetra H MPH, pubmed-author:PeraGuillemG, pubmed-author:PlebaniMarioM, pubmed-author:QuirosJose RJR, pubmed-author:RiboliElioE, pubmed-author:SaievaCalogeroC, pubmed-author:SanchezMaria-JoseMJ, pubmed-author:SimánHenrikH, pubmed-author:ThomsenReimar WRW, pubmed-author:TjonnelandAnneA, pubmed-author:TrichopoulosDimitriosD, pubmed-author:TrichoupoulouAntoniaA, pubmed-author:TuminoRosarioR, pubmed-author:VineisPaoloP, pubmed-author:WeikertCorneliaC
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
120
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
859-67
pubmed:dateRevised
2007-8-22
pubmed:meshHeading
pubmed-meshheading:17131317-Adenocarcinoma, pubmed-meshheading:17131317-Antibodies, Bacterial, pubmed-meshheading:17131317-Antigens, Bacterial, pubmed-meshheading:17131317-Bacterial Proteins, pubmed-meshheading:17131317-Cardia, pubmed-meshheading:17131317-Case-Control Studies, pubmed-meshheading:17131317-Cohort Studies, pubmed-meshheading:17131317-Helicobacter Infections, pubmed-meshheading:17131317-Helicobacter pylori, pubmed-meshheading:17131317-Humans, pubmed-meshheading:17131317-International Agencies, pubmed-meshheading:17131317-Male, pubmed-meshheading:17131317-Middle Aged, pubmed-meshheading:17131317-Prevalence, pubmed-meshheading:17131317-Prospective Studies, pubmed-meshheading:17131317-Risk Assessment, pubmed-meshheading:17131317-Risk Factors, pubmed-meshheading:17131317-Seroepidemiologic Studies, pubmed-meshheading:17131317-Stomach Neoplasms, pubmed-meshheading:17131317-Time Factors
pubmed:year
2007
pubmed:articleTitle
CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study.
More...